Showing results (2791-2800 of 3,090) with videos related to
Sort By:
Pageof 309
Drug Safety|November 30, 2017
Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 InhibitorsRebecca N Jerome, Jill M Pulley, Dan M Roden, et al.Drug Safety|December 3, 2017
Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK InhibitorsAbril Verden, Mo Dimbil, Robert Kyle, et al.Drug Safety|September 29, 2017
All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US PopulationAlyssa M Peckham, Kathleen A Fairman, David A SclarDrug Safety|July 15, 2016
Benefit-Risk Assessment of Fish Oil in Preventing Cardiovascular DiseaseBill LandsDrug Safety|September 15, 2017
Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational StudiesHuilin Tang, Shuangshuang Fu, Suodi Zhai, et al.Drug Safety|August 18, 2017
Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in ChinaYu Yang, Xiaofeng Zhou, Shuangqing Gao, et al.Drug Safety|February 28, 2018
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake InhibitorsCorine Ekhart, Florence van Hunsel, Joep Scholl, et al.Drug Safety|February 23, 2018
Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational DatabasesEd Whalen, Manfred Hauben, Andrew BateDrug Safety|March 4, 2018
Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey StudySieta T de Vries, Maartje J M van der Sar, Anna Marie Coleman, et al.Drug Safety|February 16, 2018
Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital MediaShaun Comfort, Sujan Perera, Zoe Hudson, et al.Pageof 309